SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Aloisi F (2001) Immune function of microglia. Glia 36:165179.
  • 2
    American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders, IV. American Psychiatric Association, Washington, DC.
  • 3
    Asano E, Chugani DC, Muzik O, Behen M, Janisse J, Rothermel R, Mangner TJ, Chakraborty PK, Chugani HT (2001) Autism in tuberous sclerosis complex is related to both cortical and subcortical dysfunction. Neurology 57:12691277.
  • 4
    Ashwood P, Wills S, Van de WJ (2006) The immune response in autism: a new frontier for autism research. J Leukoc Biol 80:115.
  • 5
    Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R (2003) Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13:826834.
  • 6
    Baghdadli A, Gonnier V, Aussilloux C (2002) [Review of psychopharmacological treatments in adolescents and adults with autistic disorders. Encephale 28:248254.
  • 7
    Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Yirmiya R (1998) A clinicopathological study of autism. Brain 121:889905.
  • 8
    Barnby G, Abbott A, Sykes N, Morris A, Weeks DE, Mott R, Lamb J, Bailey AJ, Monaco AP (2005) Candidate-gene screening and association analysis at the autism-susceptibility locus on chromosome 16p: evidence of association at GRIN2A and ABAT. Am J Hum Genet 76:950966.
  • 9
    Barnea-Goraly N, Kwon H, Menon V, Eliez S, Lotspeich L, Reiss AL (2004) White matter structure in autism: preliminary evidence from diffusion tensor imaging. Biol Psychiatry 55:323326.
  • 10
    Bauer J, Rauschka H, Lassmann H (2001) Inflammation in the nervous system: the human perspective. Glia 36:235243.
  • 11
    Bauman ML, Kemper TL (2005) Structural Brain Anatomy in Autism: what is the evidence? In: The Neurobiology of Autism, 2nd edn. MLBauman, TLKemper (eds), pp. 136149. The Johns Hopkins University Press: Baltimore.
  • 12
    Beilmann M, Odenthal M, Jung W, Vande Woude GF, Dienes HP, Schirmacher P (1997) Neoexpression of the c-met/hepatocyte growth factor-scatter factor receptor gene in activated monocytes. Blood 90:44504458.
  • 13
    Beilmann M, Vande Woude GF, Dienes HP, Schirmacher P (2000) Hepatocyte growth factor-stimulated invasiveness of monocytes. Blood 95:39643969.
  • 14
    Birchmeier C, Gherardi E (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends Cell Biol 8:404410.
  • 15
    Blasi F, Bacchelli E, Pesaresi G, Carone S, Bailey AJ, Maestrini E (2006) Absence of coding mutations in the X-linked genes neuroligin 3 and neuroligin 4 in individuals with autism from the IMGSAC collection. Am J Med Genet B Neuropsychiatr Genet 141:220221.
  • 16
    Blatt GJ (2005) GABAergic cerebellar system in autism: a neuropathological and developmental perspective. Int Rev Neurobiol 71:167178.
  • 17
    Blatt GJ, Fitzgerald CM, Guptill JT, Booker AB, Kemper TL, Bauman ML (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J Autism Dev Disord 31:537543.
  • 18
    Blue ME, Erzurumlu RS, Jhaveri S (1991) A comparison of pattern formation by thalamocortical and serotonergic afferents in the rat barrel field cortex. Cereb Cortex 1:380389.
  • 19
    Boccone L, Dessi V, Zappu A, Piga S, Piludu MB, Rais M, Massidda C, De VS, Cao A, Loudianos G (2006) Bannayan-Riley-Ruvalcaba syndrome with reactive nodular lymphoid hyperplasia and autism and a PTEN mutation. Am J Med Genet A 140:19651969.
  • 20
    Bolton PF, Griffiths PD (1997) Association of tuberous sclerosis of temporal lobes with autism and atypical autism. Lancet 349:392395.
  • 21
    Bolton PF, Park RJ, Higgins JN, Griffiths PD, Pickles A (2002) Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain 125:12471255.
  • 22
    Bonora E, Beyer KS, Lamb JA, Parr JR, Klauck SM, Benner A, Paolucci M, Abbott A, Ragoussis I, Poustka A, Bailey AJ, Monaco AP (2003) Analysis of reelin as a candidate gene for autism. Mol Psychiatry 8:885892.
  • 23
    Boso M, Emanuele E, Minoretti P, Arra M, Politi P, Ucelli di NS, Barale F (2006) Alterations of circulating endogenous secretory RAGE and S100A9 levels indicating dysfunction of the AGE-RAGE axis in autism. Neurosci Lett 410:169173.
  • 24
    Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 251:802804.
  • 25
    Branchi I, Francia N, Alleva E (2004) Epigenetic control of neurobehavioural plasticity: the role of neurotrophins. Behav Pharmacol 15:353362.
  • 26
    Braunschweig D, Krakowiak P, Ashwood P, Hertz-Picciotto I, Hansen L, Croen L, Pessah IN, Van de Water J. (2007) Maternal Plasma Antibodies to Human Fetal Brain in Autism. 6th International Meeting for Autism Research, Seattle, WA.
  • 27
    Buchsbaum MS, Hollander E, Haznedar MM, Tang C, Spiegel-Cohen J, Wei TC, Solimando A, Buchsbaum BR, Robins D, Bienstock C, Cartwright C, Mosovich S (2001) Effect of fluoxetine on regional cerebral metabolism in autistic spectrum disorders: a pilot study. Int J Neuropsychopharmacol 4:119125.
  • 28
    Buitelaar JK, Willemsen-Swinkels SH (2000) Medication treatment in subjects with autistic spectrum disorders. Eur Child Adolesc Psychiatry 9(Suppl.1):I85–I97.
  • 29
    Burgess NK, Sweeten TL, McMahon WM, Fujinami RS (2006) Hyperserotoninemia and altered immunity in autism. J Autism Dev Disord 36:697704.
  • 30
    Butler MG, Dasouki MJ, Zhou XP, Talebizadeh Z, Brown M, Takahashi TN, Miles JH, Wang CH, Stratton R, Pilarski R, Eng C (2005) Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet 42:318321.
  • 31
    Buxbaum JD, Cai G, Chaste P, Nygren G, Goldsmith J, Reichert J, Anckarsater H, Rastam M, Smith CJ, Silverman JM, Hollander E, Leboyer M, Gillberg C, Verloes A, Betancur C (2007) Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet 144:484491.
  • 32
    Campbell DB, Sutcliffe JS, Ebert PJ, Militerni R, Bravaccio C, Trillo S, Elia M, Schneider C, Melmed R, Sacco R, Persico AM, Levitt P (2006) A genetic variant that disrupts MET transcription is associated with autism. Proc Natl Acad Sci USA 103:1683416839.
  • 33
    Campbell DB, D'Oronzio R, Garbett K, Ebert PJ, Mirnics K, Levitt P, Persico AM (2007) Disruption of cerebral cortex MET signaling in autism spectrum disorder. Ann Neurol (in press).
  • 34
    Casanova MF, Buxhoeveden DP, Switala AE, Roy E (2002) Minicolumnar pathology in autism. Neurology 58:428432.
  • 35
    Casanova MF, Buxhoeveden D, Gomez J (2003) Disruption in the inhibitory architecture of the cell minicolumn: implications for autisim. Neuroscientist 9:496507.
  • 36
    Chandana SR, Behen ME, Juhasz C, Muzik O, Rothermel RD, Mangner TJ, Chakraborty PK, Chugani HT, Chugani DC (2005) Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism. Int J Dev Neurosci 23:171182.
  • 37
    Chauhan A, Chauhan V (2006) Oxidative stress in autism. Pathophysiology 13:171181.
  • 38
    Chauhan A, Chauhan V, Brown WT, Cohen I (2004) Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin—the antioxidant proteins. Life Sci 75:25392549.
  • 39
    Cho IH, Yoo HJ, Park M, Lee YS, Kim SA (2007): Family-based association study of 5-HTTLPR and the 5-HT2A receptor gene polymorphisms with autism spectrum disorder in Korean trios. Brain Res 1139:3441.
  • 40
    Chubykin AA, Liu X, Comoletti D, Tsigelny I, Taylor P, Sudhof TC (2005) Dissection of synapse induction by neuroligins: effect of a neuroligin mutation associated with autism. J Biol Chem 280:2236522374.
  • 41
    Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT (1999) Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann Neurol 45:287295.
  • 42
    Cisternas FA, Vincent JB, Scherer SW, Ray PN (2003) Cloning and characterization of human CADPS and CADPS2, new members of the Ca2 +-dependent activator for secretion protein family. Genomics 81:279291.
  • 43
    Comi AM, Zimmerman AW, Frye VH, Law PA, Peeden JN (1999) Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism. J Child Neurol 14:388394.
  • 44
    Comoletti D, De JA, Jennings LL, Flynn RE, Gaietta G, Tsigelny I, Ellisman MH, Taylor P (2004) The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J Neurosci 24:48894893.
  • 45
    Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C, Trillo S, Montecchi F, Schneider C, Melmed R, Elia M, Crawford L, Spence SJ, Muscarella L, Guarnieri V, D'Agruma L, Quattrone A, Zelante L, Rabinowitz D, Pascucci T, Puglisi-Allegra S, Reichelt KL, Rodier PM, Persico AM (2004) Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry 55:413419.
  • 46
    Connell S, Karikari C, Hohmann CF (2004) Sex-specific development of cortical monoamine levels in mouse. Brain Res 151:187191.
  • 47
    Connolly AM, Chez M, Streif EM, Keeling RM, Golumbek PT, Kwon JM, Riviello JJ, Robinson RG, Neuman RJ, Deuel RM (2006) Brain-derived neurotrophic factor and autoantibodies to neural antigens in sera of children with autistic spectrum disorders, Landau-Kleffner syndrome, and epilepsy. Biol Psychiatry 59:354363.
  • 48
    Cook EH (1990) Autism: review of neurochemical investigation. Synapse 6:292308.
  • 49
    Cook EH, Leventhal BL (1996) The serotonin system in autism. Curr Opin Pediatr 8:348354.
  • 50
    Cook EH Jr, Rowlett R, Jaselskis C, Leventhal BL (1992) Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry 31:739745.
  • 51
    Cook EH Jr, Arora RC, Anderson GM, Berry-Kravis EM, Yan SY, Yeoh HC, Sklena PJ, Charak DA, Leventhal BL (1993) Platelet serotonin studies in hyperserotonemic relatives of children with autistic disorder. Life Sci 52:20052015.
  • 52
    Cook EH Jr, Courchesne R, Lord C, Cox NJ, Yan S, Lincoln A, Haas R, Courchesne E, Leventhal BL (1997) Evidence of linkage between the serotonin transporter and autistic disorder. Mol Psychiatry 2:247250.
  • 53
    Coon H, Dunn D, Lainhart J, Miller J, Hamil C, Battaglia A, Tancredi R, Leppert MF, Weiss R, McMahon W (2005) Possible association between autism and variants in the brain-expressed tryptophan hydroxylase gene (TPH2). Am J Med Genet B Neuropsychiatr Genet 135:4246.
  • 54
    Courchesne E (2004) Brain development in autism: early overgrowth followed by premature arrest of growth. Ment Retard Dev Disabil Res Rev 10:106111.
  • 55
    Courchesne E, Pierce K (2005) Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci 23:153170.
  • 56
    Courchesne E, Pierce K (2005) Why the frontal cortex in autism might be talking only to itself: local over-connectivity but long-distance disconnection. Curr Opin Neurobiol 15:225230.
  • 57
    Courchesne E, Redcay E, Kennedy DP (2004) The autistic brain: birth through adulthood. Curr Opin Neurol 17:489496.
  • 58
    Coutinho AM, Sousa I, Martins M, Correia C, Morgadinho T, Bento C, Marques C, Ataide A, Miguel TS, Moore JH, Oliveira G, Vicente AM (2007) Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels. Hum Genet 121:243256.
  • 59
    Croen LA, Grether JK, Yoshida CK, Odouli R, Van de WJ (2005) Maternal autoimmune diseases, asthma and allergies, and childhood autism spectrum disorders: a case-control study. Arch Pediatr Adolesc Med 159:151157.
  • 60
    D'Amato RJ, Blue ME, Largent BL, Lynch DR, Ledbetter DJ, Molliver ME, Snyder SH (1987) Ontogeny of the serotonergic projection to rat neocortex: transient expression of a dense innervation to primary sensory areas. Proc Natl Acad Sci USA 84:43224326.
  • 61
    Daws LC, Munn JL, Valdez MF, Frosto-Burke T, Hensler JG (2007) Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem 101:641651.
  • 62
    Dawson G, Munson J, Estes A, Osterling J, McPartland J, Toth K, Carver L, Abbott R (2002) Neurocognitive function and joint attention ability in young children with autism spectrum disorder versus developmental delay. Child Dev 73:345358.
  • 63
    De Graaf-Peters VB, Hadders-Algra M (2006) Ontogeny of the human central nervous system: what is happening when? Early Hum Dev 82:257266.
  • 64
    DeLong GR, Teague LA, Swain Kamran M (1998) Effects of fluoxetine treatment in young children with idiopathic autism. Dev Med Child Neurol 40:551562.
  • 65
    Derkach VA, Oh MC, Guire ES, Soderling TR (2007) Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev 8:101113.
  • 66
    Devlin B, Bennett P, Dawson G, Figlewicz DA, Grigorenko EL, McMahon W, Minshew N, Pauls D, Smith M, Spence MA, Rodier PM, Stodgell C, Schellenberg GD (2004) Alleles of a reelin CGG repeat do not convey liability to autism in a sample from the CPEA network. Am J Med Genet B Neuropsychiatr Genet 126:4650.
  • 67
    Devlin B, Cook EH Jr, Coon H, Dawson G, Grigorenko EL, McMahon W et al (2005) Autism and the serotonin transporter: the long and short of it. Mol Psychiatry 10:11101116.
  • 68
    Dong Y, Benveniste EN (2001) Immune function of astrocytes. Glia 36:180190.
  • 69
    Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, Nygren G, Rastam M, Gillberg IC, Anckarsater H, Sponheim E, Goubran-Botros H, Delorme R, Chabane N, Mouren-Simeoni MC, De MP, Bieth E, Roge B, Heron D, Burglen L, Gillberg C, Leboyer M, Bourgeron T (2007) Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet 39:2527.
  • 70
    Eberhart CG, Copeland J, Abel TW (2006) Brief report: s6 ribosomal protein phosphorylation in autistic frontal cortex and cerebellum: a tissue array analysis. J Autism Dev Disord 36:11311135.
  • 71
    Eluvathingal TJ, Behen ME, Chugani HT, Janisse J, Bernardi B, Chakraborty P, Juhasz C, Muzik O, Chugani DC (2006) Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol 21:846851.
  • 72
    Fatemi SH, Realmuto GM, Khan L, Thuras P (1998) Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial. J Autism Dev Disord 28:303307.
  • 73
    Fatemi SH, Snow AV, Stary JM, Raghi-Niknam M, Reutiman TJ, Lee S, Brooks AI, Pearce DA (2005) Reelin signaling is impaired in autism. Biol Psychiatry 57:777787.
  • 74
    Feng J, Schroer R, Yan J, Song W, Yang C, Bockholt A, Cook EH, Jr., Skinner C, Schwartz CE, Sommer SS (2006) High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett 409:1013.
  • 75
    Fields RD, Stevens-Graham B (2002) New insights into neuron-glia communication. Science 298:556562.
  • 76
    Fombonne E, Roge B, Claverie J, Courty S, Fremolle J (1999) Microcephaly and macrocephaly in autism. J Autism Dev Disord 29:113119.
  • 77
    Forster E, Jossin Y, Zhao S, Chai X, Frotscher M, Goffinet AM (2006) Recent progress in understanding the role of Reelin in radial neuronal migration, with specific emphasis on the dentate gyrus. Eur J Neurosci 23:901909.
  • 78
    Fujimiya M, Hosoda S, Kitahama K, Kimura H, Maeda T (1986) Early development of serotonin neuron in the rat brain as studied by immunohistochemistry combined with tryptophan administration. Brain Dev 8:335342.
  • 79
    Garoflos E, Panagiotaropoulos T, Pondiki S, Stamatakis A, Philippidis E, Stylianopoulou F (2005) Cellular mechanisms underlying the effects of an early experience on cognitive abilities and affective states. Ann Gen Psychiatry 4:8 [electronic resource.
  • 80
    Gauthier J, Bonnel A, St-Onge J, Karemera L, Laurent S, Mottron L, Fombonne E, Joober R, Rouleau GA (2005) NLGN3/NLGN4 gene mutations are not responsible for autism in the Quebec population. Am J Med Genet B Neuropsychiatr Genet 132:7475.
  • 81
    Geschwind DH, Levitt P (2007) Autism spectrum disorders: developmental disconnection syndromes. Curr Opin Neurobiol 17:103111.
  • 82
    Ghaziuddin M, Tsai L, Ghaziuddin N (1991) Fluoxetine in autism with depression. J Am Acad Child Adolesc Psychiatry 30:508509.
  • 83
    Gilmore JH, Jarskog LF, Vadlamudi S (2003) Maternal infection regulates BDNF and NGF expression in fetal and neonatal brain and maternal-fetal unit of the rat. J Neuroimmunol 138:4955.
  • 84
    Goffin A, Hoefsloot LH, Bosgoed E, Swillen A, Fryns JP (2001) PTEN mutation in a family with Cowden syndrome and autism. Am J Med Genet 105:521524.
  • 85
    Gomes RA, Hampton C, El-Sabeawy F, Sabo SL, McAllister AK (2006) The dynamic distribution of TrkB receptors before, during, and after synapse formation between cortical neurons. J Neurosci 26:1148711500.
  • 86
    Graeber MB, Bise K, Mehraein P (1993) Synaptic stripping in the human facial nucleus. Acta Neuropathol (Berl) 86:179181.
  • 87
    Graf ER, Zhang X, Jin SX, Linhoff MW, Craig AM (2004) Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 119:10131026.
  • 88
    Grider MH, Mamounas LA, Le W, Shine HD (2005) In situ expression of brain-derived neurotrophic factor or neurotrophin-3 promotes sprouting of cortical serotonergic axons following a neurotoxic lesion. J Neurosci Res 82:404412.
  • 89
    Groc L, Gustafsson B, Hanse E (2006) AMPA signalling in nascent glutamatergic synapses: there and not there! Trends Neurosci 29:132139.
  • 90
    Guerin P, Lyon G, Barthelemy C, Sostak E, Chevrollier V, Garreau B, Lelord G (1996) Neuropathological study of a case of autistic syndrome with severe mental retardation. Dev Med Child Neurol 38:203211.
  • 91
    Gutierrez H, Dolcet X, Tolcos M, Davies A (2004) HGF regulates the development of cortical pyramidal dendrites. Development 131:37173726.
  • 92
    Hallbook F (1999) Evolution of the vertebrate neurotrophin and Trk receptor gene families. Curr Opin Neurobiol 9:616621.
  • 93
    Hayashi ML, Rao BS, Seo JS, Choi HS, Dolan BM, Choi SY, Chattarji S, Tonegawa S (2007) Inhibition of p21-activated kinase rescues symptoms of fragile X syndrome in mice. Proc Natl Acad Sci USA 104:1148911494.
  • 94
    Hazell P (2007) Drug therapy for attention-deficit/hyperactivity disorder-like symptoms in autistic disorder. J Paediatr Child Health 43:1924.
  • 95
    Herbert MR (2005) Large brains in autism: the challenge of pervasive abnormality. Neuroscientist 11:417440.
  • 96
    Herbert MR, Ziegler DA, Deutsch CK, O'Brien LM, Lange N, Bakardjiev A, Hodgson J, Adrien KT, Steele S, Makris N, Kennedy D, Harris GJ, Caviness VS, Jr (2003) Dissociations of cerebral cortex, subcortical and cerebral white matter volumes in autistic boys. Brain 126:11821192.
  • 97
    Herbert MR, Ziegler DA, Makris N, Filipek PA, Kemper TL, Normandin JJ, Sanders HA, Kennedy DN, Caviness VS, Jr (2004) Localization of white matter volume increase in autism and developmental language disorder. Ann Neurol 55:530540.
  • 98
    Herbert MR, Russo JP, Yang S, Roohi J, Blaxill M, Kahler SG et al (2006) Autism and environmental genomics. Neurotoxicology 27:671684.
  • 99
    Herman GE, Butter E, Enrile B, Pastore M, Prior TW, Sommer A (2007) Increasing knowledge of PTEN germline mutations: two additional patients with autism and macrocephaly. Am J Med Genet A 143:589593.
  • 100
    Hohmann CF, Hamon R, Batshaw ML, Coyle JT (1988) Transient postnatal elevation of serotonin levels in mouse neocortex. Brain Res 471:163166.
  • 101
    Hollander E, Phillips A, Chaplin W, Zagursky K, Novotny S, Wasserman S, Iyengar R (2005) A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 30:582589.
  • 102
    Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677736.
  • 103
    Hutsler JJ, Love T, Zhang H (2007) Histological and magnetic resonance imaging assessment of cortical layering and thickness in autism spectrum disorders. Biol Psychiatry 61:449457.
  • 104
    International Molecular Genetic Study of Autism Consortium (2001) Further characterization of the autism susceptibility locus AUTS1 on chromosome 7q. Hum Mol Genet 10:973982.
  • 105
    Jamain S, Betancur C, Quach H, Philippe A, Fellous M, Giros B, Gillberg C, Leboyer M, Bourgeron T (2002) Linkage and association of the glutamate receptor 6 gene with autism. Mol Psychiatry 7:302310.
  • 106
    Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC, Soderstrom H, Giros B, Leboyer M, Gillberg C, Bourgeron T (2003) Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34:2729.
  • 107
    James SJ, Cutler P, Melnyk S, Jernigan S, Janak L, Gaylor DW, Neubrander JA (2004) Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am J Clin Nutr 80:16111617.
  • 108
    James SJ, Melnyk S, Jernigan S, Cleves MA, Halsted CH, Wong DH, Cutler P, Bock K, Boris M, Bradstreet JJ, Baker SM, Gaylor DW (2006) Metabolic endophenotype and related genotypes are associated with oxidative stress in children with autism. Am J Med Genet B Neuropsychiatr Genet 141:947956.
  • 109
    Jaworski J, Spangler S, Seeburg DP, Hoogenraad CC, Sheng M (2005) Control of dendritic arborization by the phosphoinositide-3′-kinase-Akt-mammalian target of rapamycin pathway. J Neurosci 25:1130011312.
  • 110
    Junaid MA, Pullarkat RK (2001) Proteomic approach for the elucidation of biological defects in autism. J Autism Dev Disord 31:557560.
  • 111
    Juurlink BH, Paterson PG (1998) Review of oxidative stress in brain and spinal cord injury: suggestions for pharmacological and nutritional management strategies. J Spinal Cord Med 21:309334.
  • 112
    Kemper TL, Bauman M (1998) Neuropathology of infantile autism. J Neuropathol Exp Neurol 57:645652.
  • 113
    Kern JK, Jones AM (2006) Evidence of toxicity, oxidative stress, and neuronal insult in autism. J Toxicol Environ Health B Crit Rev 9:485499.
  • 114
    Kolevzon A, Mathewson KA, Hollander E (2006) Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry 67:407414.
  • 115
    Korhonen L, Sjoholm U, Takei N, Kern MA, Schirmacher P, Castren E, Lindholm D (2000) Expression of c-Met in developing rat hippocampus: evidence for HGF as a neurotrophic factor for calbindin D-expressing neurons. Eur J Neurosci 12:34533461.
  • 116
    Korvatska E, Van de WJ, Anders TF, Gershwin ME (2002) Genetic and immunologic considerations in autism. Neurobiol Dis 9:107125.
  • 117
    Koshino H, Carpenter PA, Minshew NJ, Cherkassky VL, Keller TA, Just MA (2005) Functional connectivity in an fMRI working memory task in high-functioning autism. Neuroimage 24:810821.
  • 118
    Krebs MO, Betancur C, Leroy S, Bourdel MC, Gillberg C, Leboyer M (2002) Absence of association between a polymorphic GGC repeat in the 5′ untranslated region of the reelin gene and autism. Mol Psychiatry 7:801804.
  • 119
    Kuipers SD, Bramham CR (2006) Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy. Curr Opin Drug Discov Devel 9:580586.
  • 120
    Kwon CH, Zhu X, Zhang J, Knoop LL, Tharp R, Smeyne RJ, Eberhart CG, Burger PC, Baker SJ (2001) Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease. Nat Genet 29:404411.
  • 121
    Kwon CH, Luikart BW, Powell CM, Zhou J, Matheny SA, Zhang W, Li Y, Baker SJ, Parada LF (2006) Pten regulates neuronal arborization and social interaction in mice. Neuron 50:377388.
  • 122
    Lainhart JE, Piven J, Wzorek M, Landa R, Santangelo SL, Coon H, Folstein SE (1997) Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry 36:282290.
  • 123
    Lam KS, Aman MG, Arnold LE (2006) Neurochemical correlates of autistic disorder: a review of the literature. Res Dev Disabil 27:254289.
  • 124
    Landa RJ, Holman KC, Garrett-Mayer E (2007) Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders. Arch Gen Psychiatry 64:853864.
  • 125
    Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP, Raynaud M, Ronce N, Lemonnier E, Calvas P, Laudier B, Chelly J, Fryns JP, Ropers HH, Hamel BC, Andres C, Barthelemy C, Moraine C, Briault S (2004) X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74:552557.
  • 126
    Levitt P (2005) Disruption of interneuron development. Epilepsia 46(Suppl.7):2228.
  • 127
    Levitt P, Eagleson KL, Powell EM (2004) Regulation of neocortical interneuron development and the implications for neurodevelopmental disorders. Trends Neurosci 27:400406.
  • 128
    Licinio J, Alvarado I, Wong ML (2002) Autoimmunity in autism. Mol Psychiatry 7:329.
  • 129
    Lord C, Cook EH, Leventhal BL, Amaral DG (2000) Autism spectrum disorders. Neuron 28:355363.
  • 130
    Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L (1999)Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:1523915244.
  • 131
    Ma DQ, Whitehead PL, Menold MM, Martin ER, Shley-Koch AE, Mei H, Ritchie MD, DeLong GR, Abramson RK, Wright HH, Cuccaro ML, Hussman JP, Gilbert JR, Pericak-Vance MA (2005) Identification of significant association and gene-gene interaction of GABA receptor subunit genes in autism. Am J Hum Genet 77:377388.
  • 132
    Macarov M, Zeigler M, Newman JP, Strich D, Sury V, Tennenbaum A, Meiner V (2007) Deletions of VCX-A and NLGN4: a variable phenotype including normal intellect. J Intellect Disabil Res 51:329333.
  • 133
    Mamounas LA, Altar CA, Blue ME, Kaplan DR, Tessarollo L, Lyons WE (2000) BDNF promotes the regenerative sprouting, but not survival, of injured serotonergic axons in the adult rat brain. J Neurosci 20:771782.
  • 134
    Manent JB, Represa A (2007) Neurotransmitters and brain maturation: early paracrine actions of GABA and glutamate modulate neuronal migration. Neuroscientist 13:268279.
  • 135
    Manning MA, Cassidy SB, Clericuzio C, Cherry AM, Schwartz S, Hudgins L, Enns GM, Hoyme HE (2004) Terminal 22q deletion syndrome: a newly recognized cause of speech and language disability in the autism spectrum. Pediatrics 114:451457.
  • 136
    Mattson MP, Maudsley S, Martin B (2004) BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends Neurosci 27:589594.
  • 137
    Mazer C, Muneyyirci J, Taheny K, Raio N, Borella A, Whitaker-Azmitia P (1997) Serotonin depletion during synaptogenesis leads to decreased synaptic density and learning deficits in the adult rat: a possible model of neurodevelopmental disorders with cognitive deficits. Brain Res 760:6873.
  • 138
    McAllister AK (2001) Neurotrophins and neuronal differentiation in the central nervous system. Cell Mol Life Sci 58:10541060.
  • 139
    McAllister AK (2002) Neurotrophins and cortical development. Results Probl Cell Differ 39:89112.
  • 140
    McBride PA, Anderson GM, Hertzig ME, Snow ME, Thompson SM, Khait VD et al (1998) Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiatry 37:767776.
  • 141
    McCaffery P, Deutsch CK (2005) Macrocephaly and the control of brain growth in autistic disorders. Prog Neurobiol 77:3856.
  • 142
    McDougle CJ, Naylor ST, Cohen DJ, Aghajanian GK, Heninger GR, Price LH (1996) Effects of tryptophan depletion in drug-free adults with autistic disorder. Arch Gen Psychiatry 53:9931000.
  • 143
    McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P (2000) Research Units on Pediatric Psychopharmacology (RUPP) Autism Network. Background and rationale for an initial controlled study of risperidone. Child Adolesc Psychiatr Clin N Am 9:201224.
  • 144
    Meldrum BS (2000) Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130:1007.
  • 145
    Meyer G, Varoqueaux F, Neeb A, Oschlies M, Brose N (2004) The complexity of PDZ domain-mediated interactions at glutamatergic synapses: a case study on neuroligin. Neuropharmacology 47:724733.
  • 146
    Minshew N (2001) What are neuropeptides and neurotrophins and why are they important in autism? J Autism Dev Disord 31:517.
  • 147
    Minshew NJ, Williams DL (2007) The new neurobiology of autism: cortex, connectivity, and neuronal organization. Arch Neurol 64:945950.
  • 148
    Miyazaki K, Narita N, Sakuta R, Miyahara T, Naruse H, Okado N, Narita M (2004) Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 26:292295.
  • 149
    Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Court P, Altaye M, Wills-Karp M (2006) Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 172:198205.
  • 150
    Moore ML, Eichner SF, Jones JR (2004) Treating functional impairment of autism with selective serotonin-reuptake inhibitors. Ann Pharmacother 38:15151519.
  • 151
    Mountcastle VB (1997) The columnar organization of the neocortex. Brain 120:701722.
  • 152
    Murphy DG, Daly E, Schmitz N, Toal F, Murphy K, Curran S et al (2006) Cortical serotonin 5-HT2A receptor binding and social communication in adults with Asperger's syndrome: an in vivo SPECT study. Am J Psychiatry 163:934936.
  • 153
    Nassenstein C, Kutschker J, Tumes D, Braun A (2006) Neuro-immune interaction in allergic asthma: role of neurotrophins. Biochem Soc Trans 34:591593.
  • 154
    Nedergaard M, Takano T, Hansen AJ (2002) Beyond the role of glutamate as a neurotransmitter. Nat Rev Neurosci 3:748755.
  • 155
    Nelson KB, Grether JK, Croen LA, Dambrosia JM, Dickens BF, Jelliffe LL, Hansen RL, Phillips TM (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 49:597606.
  • 156
    Nett-Clarke CA, Leslie MJ, Lane RD, Rhoades RW (1994) Effect of serotonin depletion on vibrissa-related patterns of thalamic afferents in the rat's somatosensory cortex. J Neurosci 14:75947607.
  • 157
    Neumann H (2001) Control of glial immune function by neurons. Glia 36:191199.
  • 158
    Neumeister A, Yuan P, Young TA, Bonne O, Luckenbaugh DA, Charney DS, Manji H (2005) Effects of tryptophan depletion on serum levels of brain-derived neurotrophic factor in unmedicated patients with remitted depression and healthy subjects. Am J Psychiatry 162:805807.
  • 159
    Newschaffer CJ, Croen LA, Daniels J, Giarelli E, Grether JK, Levy SE, Mandell DS, Miller LA, Pinto-Martin J, Reaven J, Reynolds AM, Rice CE, Schendel D, Windham GC (2007) The epidemiology of autism spectrum disorders. Annu Rev Public Health 28:235258.
  • 160
    Nishimura Y, Martin CL, Vazquez-Lopez A, Spence SJ, Varez-Retuerto AI, Sigman M, Steindler C, Pellegrini S, Schanen NC, Warren ST, Geschwind DH (2007) Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Hum Mol Genet 16:16821698.
  • 161
    Okunishi K, Dohi M, Nakagome K, Tanaka R, Mizuno S, Matsumoto K, Miyazaki Ji, Nakamura T, Yamamoto K (2005) A novel role of hepatocyte growth factor as an immune regulator through suppressing dendritic cell function. J Immunol 175:47454753.
  • 162
    Osterheld-Haas MC, Hornung JP (1996) Laminar development of the mouse barrel cortex: effects of neurotoxins against monoamines. Exp Brain Res 110:183195.
  • 163
    Pardo CA, Vargas DL, Zimmerman AW (2005) Immunity, neuroglia and neuroinflammation in autism. Int Rev Psychiatry 17:485495.
  • 164
    Persico AM, Bourgeron T (2006) Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci 29:349358.
  • 165
    Persico AM, Altamura C, Calia E, Puglisi-Allegra S, Ventura R, Lucchese F, Keller F (2000) Serotonin depletion and barrel cortex development: impact of growth impairment vs. serotonin effects on thalamocortical endings. Cereb Cortex 10:181191.
  • 166
    Persico AM, D'Agruma L, Maiorano N, Totaro A, Militerni R, Bravaccio C, Wassink TH, Schneider C, Melmed R, Trillo S, Montecchi F, Palermo M, Pascucci T, Puglisi-Allegra S, Reichelt KL, Conciatori M, Marino R, Quattrocchi CC, Baldi A, Zelante L, Gasparini P, Keller F (2001) Reelin gene alleles and haplotypes as a factor predisposing to autistic disorder. Mol Psychiatry 6:150159.
  • 167
    Pilarski R, Eng C (2004) Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323326.
  • 168
    Posey DJ, Erickson CA, Stigler KA, McDougle CJ (2006) The use of selective serotonin reuptake inhibitors in autism and related disorders. J Child Adolesc Psychopharmacol 16:181186.
  • 169
    Powell EM, Mars WM, Levitt P (2001) Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon. Neuron 30:7989.
  • 170
    Powell EM, Muhlfriedel S, Bolz J, Levitt P (2003) Differential regulation of thalamic and cortical axonal growth by hepatocyte growth factor/scatter factor. Dev Neurosci 25:197206.
  • 171
    Prange O, Wong TP, Gerrow K, Wang YT, El-Husseini A (2004) A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin. Proc Natl Acad Sci USA 101:1391513920.
  • 172
    Prat A, Biernacki K, Wosik K, Antel JP (2001) Glial cell influence on the human blood-brain barrier. Glia 36:145155.
  • 173
    Purcell AE, Jeon OH, Zimmerman AW, Blue ME, Pevsner J (2001) Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 57:16181628.
  • 174
    Rapin I (1997) Autism. N Engl J Med 337:97104.
  • 175
    Rapin I (2002) The autistic-spectrum disorders. N Engl J Med 347:302303.
  • 176
    Rapin I, Katzman R (1998) Neurobiology of autism. Ann Neurol 43:714.
  • 177
    Raymond GV, Bauman ML, Kemper TL (1996) Hippocampus in autism: a Golgi analysis. Acta Neuropathol (Berl) 91:117119.
  • 178
    Rhoades RW, Nett-Clarke CA, Chiaia NL, White FA, MacDonald GJ, Haring JH, Jacquin MF (1990) Development and lesion induced reorganization of the cortical representation of the rat's body surface as revealed by immunocytochemistry for serotonin. J Comp Neurol 293:190207.
  • 179
    Riikonen R (2003) Neurotrophic factors in the pathogenesis of Rett syndrome. J Child Neurol 18:693697.
  • 180
    Rolf LH, Haarmann FY, Grotemeyer KH, Kehrer H (1993) Serotonin and amino acid content in platelets of autistic children. Acta Psychiatr Scand 87:312316.
  • 181
    Sacco R, Papaleo V, Hager J, Rousseau F, Moessner R, Militerni R, Bravaccio C, Trillo S, Schneider C, Melmed R, Elia M, Curatolo P, Manzi B, Pascucci T, Puglisi-Allegra S, Reichelt KL, Persico AM (2007) Case-control and family-based association studies of candidate genes in autistic disorder and its endophenotypes: tPH2 and GLO1. BMC Med Genet 8:11.
  • 182
    Sacco R, Militerni R, Frolli A, Bravaccio C, Gritti A, Elia M et al (2007) Clinical, morphological, and biochemical correlates of head circumference in autism. Biol Psychiatry i.
  • 183
    Sadakata T, Kakegawa W, Mizoguchi A, Washida M, Katoh-Semba R, Shutoh F, Okamoto T, Nakashima H, Kimura K, Tanaka M, Sekine Y, Itohara S, Yuzaki M, Nagao S, Furuichi T (2007) Impaired cerebellar development and function in mice lacking CAPS2, a protein involved in neurotrophin release. J Neurosci 27:24722482.
  • 184
    Sadakata T, Washida M, Furuichi T (2007) Alternative splicing variations in mouse CAPS2: differential expression and functional properties of splicing variants. BMC Neurosci 8:25.
  • 185
    Salichon N, Gaspar P, Upton AL, Picaud S, Hanoun N, Hamon M, De Maeyer E, Murphy DL, Mossner R, Lesch KP, Hen R, Seif I (2001) Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci 21:884896.
  • 186
    Salinger WL, Ladrow P, Wheeler C (2003) Behavioral phenotype of the reeler mutant mouse: effects of RELN gene dosage and social isolation. Behav Neurosci 117:12571275.
  • 187
    Schellenberg GD, Dawson G, Sung YJ, Estes A, Munson J, Rosenthal E, Rothstein J, Flodman P, Smith M, Coon H, Leong L, Yu CE, Stodgell C, Rodier PM, Spence MA, Minshew N, McMahon WM, Wijsman EM (2006) Evidence for multiple loci from a genome scan of autism kindreds. Mol Psychiatry 11:10491060.
  • 188
    Schmitz C, Van Kooten IA, Hof PR, Van Engeland H, Patterson PH, Steinbusch HW (2005) Autism: neuropathology, alterations of the GABAergic system, and animal models. Int Rev Neurobiol 71:126.
  • 189
    Schroer RJ, Phelan MC, Michaelis RC, Crawford EC, Skinner SA, Cuccaro M, Simensen RJ, Bishop J, Skinner C, Fender D, Stevenson RE (1998) Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet 76:327336.
  • 190
    Schumann CM, Amaral DG (2005) Stereological estimation of the number of neurons in the human amygdaloid complex. J Comp Neurol 491:320329.
  • 191
    Schumann CM, Amaral DG (2006) Stereological analysis of amygdala neuron number in autism. J Neurosci 26:76747679.
  • 192
    Schumann CM, Hamstra J, Goodlin-Jones BL, Lotspeich LJ, Kwon H, Buonocore MH, Lammers CR, Reiss AL, Amaral DG (2004) The amygdala is enlarged in children but not adolescents with autism; the hippocampus is enlarged at all ages. J Neurosci 24:63926401.
  • 193
    Scott MM, Deneris ES (2005) Making and breaking serotonin neurons and autism. Int J Dev Neurosci 23:277285.
  • 194
    Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtimaki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M (2007) Strong association of de novo copy number mutations with autism. Science 316:445449.
  • 195
    Serajee FJ, Zhong H, Nabi R, Huq AH (2003) The metabotropic glutamate receptor 8 gene at 7q31: partial duplication and possible association with autism. J Med Genet 40:e42.
  • 196
    Serajee FJ, Zhong H, Mahbubul Huq AH (2006) Association of Reelin gene polymorphisms with autism. Genomics 87:7583.
  • 197
    Shoval G, Weizman A (2005) The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia. Eur Neuropsychopharmacol 15:319329.
  • 198
    Shuang M, Liu J, Jia MX, Yang JZ, Wu SP, Gong XH, Ling YS, Ruan Y, Yang XL, Zhang D (2004) Family-based association study between autism and glutamate receptor 6 gene in Chinese Han trios. Am J Med Genet B Neuropsychiatr Genet 131:4850.
  • 199
    Skaar DA, Shao Y, Haines JL, Stenger JE, Jaworski J, Martin ER, DeLong GR, Moore JH, McCauley JL, Sutcliffe JS, Shley-Koch AE, Cuccaro ML, Folstein SE, Gilbert JR, Pericak-Vance MA (2005) Analysis of the RELN gene as a genetic risk factor for autism. Mol Psychiatry 10:563571.
  • 200
    Smalley SL (1998) Autism and tuberous sclerosis. J Autism Dev Disord 28:407414.
  • 201
    Smith IM, Nichols SL, Issekutz K, Blake K (2005) Behavioral profiles and symptoms of autism in CHARGE syndrome: preliminary Canadian epidemiological data. Am J Med Genet A 133:248256.
  • 202
    Strutz-Seebohm N, Korniychuk G, Schwarz R, Baltaev R, Ureche ON, Mack AF, DeLong GR, Moore JH, McCauley JL, Sutcliffe JS, Shley-Koch AE, Cuccaro ML, Folstein SE, Gilbert JR, Pericak-Vance MA (2006) Functional significance of the kainate receptor GluR6(M836I) mutation that is linked to autism. Cell Physiol Biochem 18:287294.
  • 203
    Sun W, Funakoshi H, Nakamura T (2002) Localization and functional role of hepatocyte growth factor (HGF) and its receptor c-met in the rat developing cerebral cortex. Brain Res Mol Brain Res 103:3648.
  • 204
    Sutcliffe JS, Delahanty RJ, Prasad HC, McCauley JL, Han Q, Jiang L, Li C, Folstein SE, Blakely RD (2005) Allelic heterogeneity at the serotonin transporter locus (SLC6A4) confers susceptibility to autism and rigid-compulsive behaviors. Am J Hum Genet 77:265279.
  • 205
    Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ, Vincent JB, Skaug JL, Thompson AP, Senman L, Feuk L, Qian C, Bryson SE, Jones MB, Marshall CR, Scherer SW, Vieland VJ, Bartlett C, Mangin LV, Goedken R, Segre A, Pericak-Vance MA, Cuccaro ML, Gilbert JR, Wright HH, Abramson RK, Betancur C, Bourgeron T, Gillberg C, Leboyer M, Buxbaum JD, Davis KL, Hollander E, Silverman JM, Hallmayer J, Lotspeich L, Sutcliffe JS, Haines JL, Folstein SE, Piven J, Wassink TH, Sheffield V, Geschwind DH, Bucan M, Brown WT, Cantor RM, Constantino JN, Gilliam TC, Herbert M, Lajonchere C, Ledbetter DH, Lese-Martin C, Miller J, Nelson S, Samango-Sprouse CA, Spence S, State M, Tanzi RE, Coon H, Dawson G, Devlin B, Estes A, Flodman P, Klei L, McMahon WM, Minshew N, Munson J, Korvatska E, Rodier PM, Schellenberg GD, Smith M, Spence MA, Stodgell C, Tepper PG, Wijsman EM, Yu CE, Roge B, Mantoulan C, Wittemeyer K, Poustka A, Felder B, Klauck SM, Schuster C, Poustka F, Bolte S, Feineis-Matthews S, Herbrecht E, Schmotzer G, Tsiantis J, Papanikolaou K, Maestrini E, Bacchelli E, Blasi F, Carone S, Toma C, Van EH, De JM, Kemner C, Koop F, Langemeijer M, Hijimans C, Staal WG, Baird G, Bolton PF, Rutter ML, Weisblatt E, Green J, Aldred C, Wilkinson JA, Pickles A, Le CA, Berney T, McConachie H, Bailey AJ, Francis K, Honeyman G, Hutchinson A, Parr JR, Wallace S, Monaco AP, Barnby G, Kobayashi K, Lamb JA, Sousa I, Sykes N, Cook EH, Guter SJ, Leventhal BL, Salt J, Lord C, Corsello C, Hus V, Weeks DE, Volkmar F, Tauber M, Fombonne E, Shih A (2007) Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39:319328.
  • 206
    Tabakman R, Lecht S, Sephanova S, Rien-Zakay H, Lazarovici P (2004) Interactions between the cells of the immune and nervous system: neurotrophins as neuroprotection mediators in CNS injury. Prog Brain Res 146:387401.
  • 207
    Talebizadeh Z, Lam DY, Theodoro MF, Bittel DC, Lushington GH, Butler MG (2006) Novel splice isoforms for NLGN3 and NLGN4 with possible implications in autism. J Med Genet 43:e21.
  • 208
    Torrente F, Ashwood P, Day R, Machado N, Furlano RI, Anthony A, Davies SE, Wakefield AJ, Thomson MA, Walker-Smith JA, Murch SH (2002) Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry 7:375382, 334.
  • 209
    Ullian EM, Christopherson KS, Barres BA (2004) Role for glia in synaptogenesis. Glia 47:209216.
  • 210
    Vaidya VA, Terwilliger RM, Duman RS (1999) Role of 5-HT2A receptors in the stress-induced down-regulation of brain-derived neurotrophic factor expression in rat hippocampus. Neurosci Lett 262:14.
  • 211
    Vargas DL, Nascimbene C, Krishnan C, Zimmerman AW, Pardo CA (2005) Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 57:6781.
  • 212
    Vincent JB, Kolozsvari D, Roberts WS, Bolton PF, Gurling HM, Scherer SW (2004) Mutation screening of X-chromosomal neuroligin genes: no mutations in 196 autism probands. Am J Med Genet B Neuropsychiatr Genet 129:8284.
  • 213
    Wassink TH, Hazlett HC, Epping EA, Arndt S, Dager SR, Schellenberg GD, Dawson G, Piven J (2007) Cerebral cortical gray matter overgrowth and functional variation of the serotonin transporter gene in autism. Arch Gen Psychiatry 64:709717.
  • 214
    Weiss LA, Kosova G, Delahanty RJ, Jiang L, Cook EH, Ober C, Sutcliffe JS (2006) Variation in ITGB3 is associated with whole-blood serotonin level and autism susceptibility. Eur J Hum Genet 14:923931.
  • 215
    Weiss LA, Ober C, Cook EH Jr (2006) ITGB3 shows genetic and expression interaction with SLC6A4. Hum Genet 120:93100.
  • 216
    Williams KC, Hickey WF (2002) Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS. Annu Rev Neurosci 25:537562.
  • 217
    Yamakawa H, Oyama S, Mitsuhashi H, Sasagawa N, Uchino S, Kohsaka S, Ishiura S (2007)Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations. Biochem Biophys Res Commun 355:4146.
  • 218
    Yan J, Oliveira G, Coutinho A, Yang C, Feng J, Katz C, Sram J, Bockholt A, Jones IR, Craddock N, Cook EH, Jr., Vicente A, Sommer SS (2005) Analysis of the neuroligin 3 and 4 genes in autism and other neuropsychiatric patients. Mol Psychiatry 10:329332.
  • 219
    Yan W, Wilson CC, Haring JH (1997) 5-HT1a receptors mediate the neurotrophic effect of serotonin on developing dentate granule cells. Brain Res 98:185190.
  • 220
    Yang MS, Gill M (2007) A review of gene linkage, association and expression studies in autism and an assessment of convergent evidence. Int J Dev Neurosci 25:6985.
  • 221
    Ylisaukko-Oja T, Rehnstrom K, Auranen M, Vanhala R, Alen R, Kempas E, Ellonen P, Turunen JA, Makkonen I, Riikonen R, Nieminen-von WT, Von WL, Peltonen L, Jarvela I (2005) Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet 13:12851292.
  • 222
    Yorbik O, Sayal A, Akay C, Akbiyik DI, Sohmen T (2002) Investigation of antioxidant enzymes in children with autistic disorder. Prostaglandins Leukot Essent Fatty Acids 67:341343.
  • 223
    Zetterstrom TS, Pei Q, Madhav TR, Coppell AL, Lewis L, Grahame-Smith DG (1999) Manipulations of brain 5-HT levels affect gene expression for BDNF in rat brain. Neuropharmacology 38:10631073.
  • 224
    Zhang H, Liu X, Zhang C, Mundo E, Macciardi F, Grayson DR, Guidotti AR, Holden JJ (2002) Reelin gene alleles and susceptibility to autism spectrum disorders. Mol Psychiatry 7:10121017.
  • 225
    Zimmerman AW, Connors SL, Pardo CA (2006) Neuroimmunology and neurotransmitters in autism. In: Autism: A Neurological Disorder of Early Brain Development. RTuchman, IRapin (eds), pp. 141159. International Child Neurology Association: London, Mac Keith Press.
  • 226
    Zimmerman AW, Connors SL, Matteson KJ, Lee LC, Singer HS, Castaneda JA, Pearce DA (2007) Maternal antibrain antibodies in autism. Brain Behav Immun 21:351357.
  • 227
    Zoghbi HY (2003) Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302:826830.
  • 228
    Zori RT, Marsh DJ, Graham GE, Marliss EB, Eng C (1998) Germline PTEN mutation in a family with Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Med Genet 80:399402.
  • 229
    Zoroglu SS, Armutcu F, Ozen S, Gurel A, Sivasli E, Yetkin O, Meram I (2004) Increased oxidative stress and altered activities of erythrocyte free radical scavenging enzymes in autism. Eur Arch Psychiatry Clin Neurosci 254:143147.